Strategic Outsourcing Deals. List of Preferred CRO's by Pharma Company. Please add comment and I will update Amgen - PRA Astellas - INC Research AstraZeneca - Quintiles Bayer AG - Covance Bristol-Myers Squibb - ICON, Parexel Celtic Therapeutics - PPD Eisai - PPD Elan - PPD Eli Lilly - Covance, ICON, Parexel, Quintiles, Thermo Fisher , ShangPharma GlaxoSmithKline - Parexel, PPD Merck & Co. - Parexel Otsuka -Covance Pfizer - ICON, Parexel, Medco Health Solutions, WuXi Sanofi - Covance, Medco Health Solutions Shire - ICON Takeda - Covance, Quintiles UCB - Parexel, PRA
Friday, 3 August 2012
Clinical Outsourcing - Strategic Clinical Outsourcing Deals.
Posted by Doctor Giles at 10:08 7 comments
Thursday, 15 October 2009
Partnerships in Clinical Trials 2009
The Eighth Partnerships in Clinical Trials meeting is to take place 4-5 November 2009 at the World Trade Centre, Rotterdam in The Netherlands.
This is one of the premier European events for the Clinical Outsourcing Community from the Sponsor(Pharma/BioPharma/BioTech) and the Vendor/CRO point of view.
This year speakers include:
Anatole Kaletsky - from the Times
John Sergeant - Chairman
and a who's who from the world of Pharmaceuticals.
Are you going?
If you are not going - why not? Share your views and reviews via the comments section.
Posted by Doctor Giles at 22:05 1 comments
Thursday, 12 February 2009
Relationship Management
How does your organisation deal with Relationship Management.
This is a key competancy that is ofter overlooked or under resourced.
How do you manage your supply base or customer base.
Is there a specific person who does this.
What skills do they have - are they appropriate.
Supplier Governance and Supplier relationship management are areas to invest in during a downturn.
Do it today
Posted by Doctor Giles at 14:42 0 comments
Friday, 26 September 2008
GlaxoSmithKline Clinical Study Register Launches Today
Today marks a new dawn in Clinical Trial reporting and transparity.
Moving forward from the GSK Clinical Trial Register, the new site is called GlaxoSmithKline Clinical Study Register.
More information for the public, patients, media and the medical professionals.
http://clinicalstudyregister.comhttp://clinicalstudyregister.com
Posted by Doctor Giles at 11:03 0 comments
Monday, 22 September 2008
Books
Could be an interesting book
What are you reading at the mo...
This looks good
Janssen
Posted by Doctor Giles at 16:53 0 comments
Pharma Giles
The " Tribute to PharmaGiles " post has become very popular.
It has been mentioned on several other blogs already
Does anyone else have any PharmaGiles memorabilia/memories/pictures/documents etc.
Please let me know if you want the pdf of Pharma Giles Childrens Book of Medicine.
Link
Posted by Doctor Giles at 15:51 1 comments
Thursday, 28 August 2008
Friday, 1 August 2008
Supplier Performance Monitoring
The purpose of Supplier Performance Monitoring is to:
• Clearly communicate ‘COMPANY X’ supplier performance goals and expectations.
• Jointly agree a supplier’s current supply capability and performance whilst identifying areas for improvement to meet ‘COMPANY X’’s needs.
• Provide a framework to identify performance gaps for planning improvement action.
• Capture actual supplier performance for feedback to ‘COMPANY X’ and supplier stakeholders.
• Facilitate a review of supplier performance against targets and best in class.
• Maintain a record of supplier performance against Business Requirements over time.
• Allow easy comparison of performance between similar suppliers.
When to initiate Supplier Performance Monitoring
Ideally Supplier Performance Monitoring should be outlined to potential new suppliers at the earliest opportunity. This will be in the information gathering stage of ‘PROCURMENT PROCESS’ as part of Supplier Conditioning. Full details will then be communicated in RFP/ RFQ's with formal agreement occurring within a Contract or Service Level Agreement (SLA). By positioning the principle of measurement and monitoring early in a supplier relationship, the importance of continuous improvement will be conveyed and adequate resources can be allocated to ensure ongoing professional performance management.
The tool can also be introduced into an existing supplier relationship where structured performance monitoring has not previously occurred. Senior management influence is recommended to ensure top level support to the principles of measurement and action planning for improvement. In these circumstances the tool provides a powerful means of re-focusing suppliers on current Business Requirements and priorities, reassessing their ability to deliver against these whilst assigning actions to hit higher performance levels.
Posted by Doctor Giles at 14:19 1 comments